Gender disparity in distribution of the major hydrophilic region variants of hepatitis B virus genotype C according to hepatitis B e antigen serostatus

Journal of Medical Virology

Volumn 83, Issue 3, 2011, Pages 405-411

  Lee, Seoung Ae ^a   Cho, Yoo Kyung ^b   Lee, Keun Hwa ^b   Hwang, Eung Soo ^a   Kook, Yoon Hoh ^a   Kim, Bum Joon ^a  

^a Seoul National University   (South Korea)

^b Jeju National University School of Medicine   (South Korea)

Author keywords

Gender disparity; Hepatitis B e antigen (HBeAg); Hepatitis B virus (HBV); Major hydrophilic region (MHR); Variant

Indexed keywords

HEPATITIS B(E) ANTIGEN; VIRUS DNA;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENETIC VARIABILITY; GENOTYPE; HEPATITIS B VIRUS; HUMAN; IMMUNE EVASION; IMMUNE RESPONSE; KOREA; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PROMOTER REGION; SEROCONVERSION; SEROPREVALENCE; SEX DIFFERENCE; VIRUS VIRULENCE;

ADOLESCENT; ADULT; AGED; AMINO ACID SEQUENCE; FEMALE; GENOTYPE; HEPATITIS B E ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; SEQUENCE ALIGNMENT; SEX FACTORS; YOUNG ADULT;

HEPATITIS B VIRUS;

EID: 78851472078     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21988     Document Type: Article

References (26)

1. Brown SE, Howard CR, Zuckerman AJ, Steward MW. 1984. Affinity of antibody responses in man to hepatitis B vaccine determined with synthetic peptides. Lancet 2: 184-187.
2. Brunetto MR, Rodriguez UA, Bonino F. 1999. Hepatitis B virus mutants. Intervirology 42: 69-80.
3. Cooreman MP, Leroux-Roels G, Paulij WP. 2001. Vaccine- and hepatitis B immune globulin-induced escape mutations of hepatitis B virus surface antigen. J Biomed Sci 8: 237-247.
4. Funk ML, Rosenberg DM, Lok AS. 2002. World-wide epidemiology of HBeAg negative chronic hepatitis B and associated precore and core promoter variants. J Viral Hepatol 9: 52-61.
5. Hadziyannis SJ. 1995. Hepatitis B e antigen negative chronic hepatitis B: from clinical recognition to pathogenesis and treatment. Viral Hepatitis Rev 1: 7-36.
6. Hadziyannis SJ, Vassilopoulos D. 2001. Hepatitis B e antigen-negative chronic hepatitis B. Hepatology 34: 617-624.
7. Howard CR. 1995. The structure of hepatitis B envelope and molecular variants of hepatitis B virus. J Viral Hepat 2: 165-170.
8. Kim H, Jee YM, Song BC, Shin JW, Yang SH, Mun HS, Kim HJ, Oh EJ, Yoon JH, Kim YJ, Lee HS, Hwang ES, Cha CY, Kook YH, Kim BJ. 2007. Molecular epidemiology of hepatitis B virus (HBV) genotypes and serotypes in patients with Chronic HBV infection in Korea. Intervirology 50: 52-57.
9. Kim HJ, Park JH, Jee Y, Lee SA, Kim H, Song BC, Yang S, Lee M, Yoon JH, Kim YJ, Lee HS, Hwang ES, Kook YH, Kim BJ. 2008. Hepatitis B virus X mutations occurring naturally associated with clinical severity of liver disease among Korean patients with chronic genotype C infection. J Med Virol 80: 1337-1343.
10. Lai CL, Shouval D, Lok AS, Chang TT, Cheinquer H, Goodman Z, DeHertogh D, Wilber R, Zink RC, Cross A, Colonno R, Fernandes L. BEHoLD AI463027 Study Group. 2006. Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B. N Engl J Med 9(354): 1011-1020.
11. Lampertico P, Del Ninno E, Viganò M, Romeo R, Donato MF, Sablon E, Morabito A, Colombo M. 2003. Long-term suppression of hepatitis B e antigen-negative chronic hepatitis B by 24-month interferon therapy. Hepatology 37: 756-763.
12. Laras A, Koskinas J, Avgidis K, Hadziyannis SJ. 1998. Incidence and clinical significance of hepatitis B virus precore gene translation initiation mutations in e antigen-negative patients. J Viral Hepatitis 5: 241-248.
13. Lee WM. 1997. Hepatitis B virus infection. N Engl J Med 337: 1733-1745.
14. Lee DH, Kim JH, Nam JJ, Kim HR, Shin HR. 2002. Epidemiological findings of hepatitis B infection based on 1998 National Health and Nutrition Survey in Korea. J Korean Med Sci 17: 457-462.
15. Lee KM, Kim YS, Ko YY, Yoo BM, Lee KJ, Kim JH, Hahm KB, Cho SW. 2001. Emergence of vaccine-induced escape mutant of hepatitis B virus with multiple surface gene mutations in a Korean child. J Korean Med Sci 16: 359-362.
16. Liaw YF. 2009. Natural history of chronic hepatitis B virus infection and long-term outcome under treatment. Liver Int 29: 100-107.
17. Yim HJ, Lok AS. 2006. Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005. Hepatology 43: S173-S181.
18. Lok AS, McMahon BJ. 2001. Practice Guidelines Committee, American Association for the Study of Liver Diseases. Chronic hepatitis B. Hepatology 34: 1225-1241.
19. McMahon BJ, Alberts SR, Wainwright RB, Bulkow L, Lanier AP. 1990. Hepatitis B-related sequelae. Prospective study in 1400 hepatitis B surface antigen-positive Alaska native carriers. Arch Intern Med 150: 1051-1054.
20. Papatheodoridis GV, Dimou E, Dimakopoulos K, Manolakopoulos S, Rapti I, Kitis G, Tzourmakliotis D, Manesis E, Hadziyannis SJ. 2005. Outcome of hepatitis B e antigen-negative chronic hepatitis B on long-term nucleos(t)ide analog therapy starting with lamivudine. Hepatology 42: 121-129.
21. Poynard T, Ratziu V, Charlotte F, Goodman Z, McHutchison J, Albrecht J. 2001. Rates and risk factors of liver fibrosis progression in patients with chronic Hepatitis C. J Hepatol 34: 730-739.
22. Song BC, Kim SH, Kim H, Ying YH, Kim HJ, Kim YJ, Yoon JH, Lee HS, Cha CY, Kook YH, Kim BJ. 2005. Prevalence of naturally occurring surface antigen variants of hepatitis B virus in Korean patients infected chronically. J Med Virol 76: 194-202.
23. Yoo BC, Park JW, Kim HJ, Lee DH, Cha YJ, Park SM. 2003. Precore and core promoter mutations of hepatitis B virus and hepatitis B e antigen-negative chronic hepatitis B in Korea. J Hepatol 38: 98-103.
24. Zacharakis GH, Koskinas J, Kotsiou S, Papoutselis M, Tzara F, Vafeiadis N, Archimandritis AJ, Papoutselis K. 2005. Natural history of chronic HBV infection: a cohort study with up to 12 years follow-up in North Greece (part of the Interreg I-II/EC-project). J Med Virol 77: 173-179.
25. Zuckerman AJ. 2000. Effect of hepatitis B virus mutants on efficacy of vaccination. Lancet 355: 1382-1384.
26. Zuckerman AJ, Zuckeman JN. 1999. Molecular epidemiology of hepatitis B virus mutants. J Med Virol 58: 193-195.